Thermo Fisher Scientific (TMO) Cash from Operations (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Cash from Operations for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 51.89% year-over-year to $2.1 billion; the trailing twelve-month figure through Jun 2026 stood at $9.0 billion (up 18.94% YoY), and the FY2025 full-year result was $7.8 billion, down 9.8% from the prior year.
• Cash from Operations advanced to $2.1 billion in Q2 2026 per TMO's latest filing, from $1.2 billion in the prior quarter.
• Across five years, Cash from Operations topped out at $3.7 billion in Q4 2023 and bottomed at $723.0 million in Q1 2025.
• Historically, Cash from Operations has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations tumbled 66.89% in 2023, then jumped 71.6% in 2024.
• Over 5 years, Cash from Operations stood at $3.5 billion in 2022, then gained by 6.77% to $3.7 billion in 2023, then dropped by 11.63% to $3.3 billion in 2024, then gained by 5.08% to $3.5 billion in 2025, then sank by 38.53% to $2.1 billion in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered $2.1 billion, $1.2 billion, and $3.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.